| Attributes | Values |
|---|
| rdf:type
| |
| description
| - artículu científicu espublizáu en 1999 (ast)
- vědecký článek publikovaný v roce 1999 (cs)
- наукова стаття, опублікована в серпні 1999 (uk)
- 1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած (hyw)
- 1999 թվականի օգոստոսին հրատարակված գիտական հոդված (hy)
- مقالة علمية (نشرت في أغسطس 1999) (ar)
- vedecký článok (publikovaný 1999/08/01) (sk)
- scientific journal article (en)
- im August 1999 veröffentlichter wissenschaftlicher Artikel (de)
- wetenschappelijk artikel (gepubliceerd op 1999/08/01) (nl)
|
| publication date
| |
| publication date
| |
| cites work
| |
| cites work
| |
| author name string
| |
| OpenCitations bibliographic resource ID
| |
| OpenCitations bibliographic resource ID
| |
| author name string
| - F Chang
- X Y Wang
- C Weinstein-Oppenheimer
- L S Steelman
- R A Franklin
- J A McCubrey
- P A Algate
- P E Hoyle
|
| OpenCitations bibliographic resource ID
| |
| rdfs:label
| - Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs (en)
- Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs (nl)
- Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs (ast)
|
| skos:prefLabel
| - Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs (en)
- Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs (nl)
- Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs (ast)
|
| name
| - Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs (en)
- Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs (nl)
- Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs (ast)
|
| author
| |
| author
| |
| title
| |
| title
| - Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1038/SJ.LEU.2401493
- 10.1038/SJ/LEU/2401493
|
| Springer Nature article ID
| |
| Dimensions Publication ID
| |
| Springer Nature article ID
| |
| Dimensions Publication ID
| |
| is about
of | |
| is cites work
of | - JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
- Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer
- Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells
- Engineering a CD123xCD3 bispecific scFv immunofusion for the treatment of leukemia and elimination of leukemia stem cells
- Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.
- Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase
- A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cells.
- The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors
- Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
- The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia
- Hematopoietic cytokine receptor signaling
- Calcium-induced ERK activation in human T lymphocytes occurs via p56(Lck) and CaM-kinase.
- Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells
- JAKs, STATs and Src kinases in hematopoiesis
- IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled
- Kinases: positive and negative regulators of apoptosis.
- Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.
- Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.
- In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
- TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)